Diagnosis of schizophrenia, schizoaffective disorder, schizotypal disorder, schizophreniform disorder, bipolar I or II disorder, borderline personality disorder (DSM-V criteria, APA, 2013).
Clinical stability since 3 months (total PANSS score \<120, MADRS score \<15 and YMRS \<12 for patients with schizophrenia and MADRS score \<15 and YMRS \<12 for patients with bipolar disorder).
Patients who gave informed consent to participate in the study.
Affiliated to a social security scheme or beneficiary of such a scheme.
You may not be if
Pregnant or lactating women.
Criteria relating to the associated pathologies entailing particular risks:
Neurological disorders of vascular, infectious or neurodegenerative origin.
Taking somatic drugs with a cerebral or mental impact (eg corticosteroids).
Presence of an associated intellectual disability.
Prohibited treatments and procedures:
Subject in exclusion period of another study.
Simultaneous participation in other programs having an impact on social functioning or self-stigmatization: remediation of social cognition, individual and group care targeting self-stigmatization and training in social skills.
